107 related articles for article (PubMed ID: 6386048)
1. Interaction between the A2 and A19 amino acid residues is of critical importance for high biological activity in insulin: [19-leucine-A]insulin.
Kitagawa K; Ogawa H; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1984 Sep; 23(19):4444-8. PubMed ID: 6386048
[TBL] [Abstract][Full Text] [Related]
2. Critical role of the A2 amino acid residue in the biological activity of insulin: [2-glycine-A]- and [2-alanine-A]insulins.
Kitagawa K; Ogawa H; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1984 Mar; 23(7):1405-13. PubMed ID: 6372857
[TBL] [Abstract][Full Text] [Related]
3. [A2-Norleucine]insulin. An analog with unanticipated biological properties.
Okada Y; Chanley JD; Burke GT; Katsoyannis PG
Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):629-38. PubMed ID: 7024085
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-tryptophan-A]insulin.
Ohta N; Burke GT; Katsoyannis PG
J Protein Chem; 1988 Feb; 7(1):55-65. PubMed ID: 3076448
[TBL] [Abstract][Full Text] [Related]
5. A biologically active insulin analogue with modification in the A2 position. [2-Valine-A] sheep insulin.
Ohta N; Burke GT; Katsoyannis PG
Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):670-4. PubMed ID: 2665960
[TBL] [Abstract][Full Text] [Related]
6. Importance of aliphatic side-chain structure at positions 2 and 3 of the insulin A chain in insulin-receptor interactions.
Nakagawa SH; Tager HS
Biochemistry; 1992 Mar; 31(12):3204-14. PubMed ID: 1554705
[TBL] [Abstract][Full Text] [Related]
7. The A14 position of insulin tolerates considerable structural alterations with modest effects on the biological behavior of the hormone.
Chu YC; Zong L; Burke GT; Katsoyannis PG
J Protein Chem; 1992 Oct; 11(5):571-7. PubMed ID: 1360216
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of invariant valine B12 in insulin: implications for receptor binding.
Nakagawa SH; Tager HS; Steiner DF
Biochemistry; 2000 Dec; 39(51):15826-35. PubMed ID: 11123908
[TBL] [Abstract][Full Text] [Related]
9. Divergence of the in vitro biological activity and receptor binding affinity of a synthetic insulin analogue, [21-asparaginamide-A]insulin.
Burke GT; Chanley JD; Okada Y; Cosmatos A; Ferderigos N; Katsoyannis PG
Biochemistry; 1980 Sep; 19(20):4547-56. PubMed ID: 7000179
[TBL] [Abstract][Full Text] [Related]
10. Chiral mutagenesis of insulin's hidden receptor-binding surface: structure of an allo-isoleucine(A2) analogue.
Xu B; Hua QX; Nakagawa SH; Jia W; Chu YC; Katsoyannis PG; Weiss MA
J Mol Biol; 2002 Feb; 316(3):435-41. PubMed ID: 11866509
[TBL] [Abstract][Full Text] [Related]
11. Effect of N-methylation of selected peptide bonds on the biological activity of insulin. [2-N-methylisoleucine-A]insulin and [3-N-methylvaline-A]insulin.
Ogawa H; Burke GT; Chanley JD; Katsoyannis PG
Int J Pept Protein Res; 1987 Oct; 30(4):460-73. PubMed ID: 3323092
[TBL] [Abstract][Full Text] [Related]
12. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects.
Nakagawa SH; Tager HS
J Biol Chem; 1986 Jun; 261(16):7332-41. PubMed ID: 3519607
[TBL] [Abstract][Full Text] [Related]
13. [Insulin analogues with permuted A chain N-terminus (author's transl)].
Krail G; Brandenburg D; Zahn H
Hoppe Seylers Z Physiol Chem; 1975 Jun; 356(6):981-96. PubMed ID: 1181282
[TBL] [Abstract][Full Text] [Related]
14. An insulin analogue possessing higher in vitro biological activity than receptor binding affinity. [21-Proline-B]insulin.
Schwartz GP; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1983 Sep; 22(19):4561-7. PubMed ID: 6354263
[TBL] [Abstract][Full Text] [Related]
15. [12-asparagine-B] human insulin. An analogue with modification in the hydrophobic core of insulin.
Schwartz GP; Burke GT; Katsoyannis PG
Int J Pept Protein Res; 1981 Feb; 17(2):243-55. PubMed ID: 7014485
[TBL] [Abstract][Full Text] [Related]
16. Biological potency and binding affinity of monoiodoinsulin with iodine in tyrosine A14 or tyrosine A19.
Gliemann J; Sonne O; Linde S; Hansen B
Biochem Biophys Res Commun; 1979 Apr; 87(4):1183-90. PubMed ID: 465032
[No Abstract] [Full Text] [Related]
17. Synthesis and properties of [A19-(p-fluorophenylalanine)] insulin.
Stoev S; Zakhariev S; Golovinsky E; Gattner HG; Naithani VK; Wollmer A; Brandenburg D
Biol Chem Hoppe Seyler; 1988 Dec; 369(12):1307-15. PubMed ID: 3072012
[TBL] [Abstract][Full Text] [Related]
18. Implications of invariant residue LeuB6 in insulin-receptor interactions.
Nakagawa SH; Tager HS
J Biol Chem; 1991 Jun; 266(18):11502-9. PubMed ID: 2050662
[TBL] [Abstract][Full Text] [Related]
19. Structure-function relationships of des-(B26-B30)-insulin.
Spoden M; Gattner HG; Zahn H; Brandenburg D
Int J Pept Protein Res; 1995; 46(3-4):221-7. PubMed ID: 8537175
[TBL] [Abstract][Full Text] [Related]
20. (A1-phenylalanine) insulin: a new synthetic analogue.
Danho W; Sasaki A; Büllesbach E; Föhles J; Gattner HG
Hoppe Seylers Z Physiol Chem; 1980 May; 361(5):735-46. PubMed ID: 7000656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
